Sign inJoin waitlistJoin the waitlist

Martin King

Director, Brachytherapy Clinical Operations · Mass General Brigham

Credentials: · · · · · · · ·

History

Mass General Brigham
Present

Memorial Sloan Kettering Cancer Center
2015–2016
Radiation Oncology
Stanford University Medical Center
2011–2015
Endeavor Health
2010–2011
University of Chicago Division of the Biological Sciences, The Pritzker School of Medicine
2006–2010

Research

Biochemical recurrence in patients with prostate cancer after primary definitive therapy: treatment based on risk stratification
Review · Prostate Cancer and Prostatic Diseases · 2024 · 126 citations
Cost-Effectiveness of Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer
Journal of Clinical Oncology · 2016 · 90 citations
Hyaluronic Acid Spacer for Hypofractionated Prostate Radiation Therapy: A Randomized Clinical Trial
JAMA Oncology · 2023 · Last of 23 authors · Corresponding · 85 citations

Peter Orio
47 papers
Paul Nguyen
38 papers
Anthony D'Amico
23 papers
David Yang
23 papers · 13 as a resident
VM
Vinayak Muralidhar
20 papers · 20 as a resident
Neil Martin
19 papers
Kent Mouw
17 papers
LL
Larissa Lee
17 papers
Brandon Mahal
16 papers · 16 as a resident
Jonathan Leeman
13 papers · 1 as a resident
Mutlay Sayan
11 papers
Quoc-Dien Trinh
11 papers

Clinical trials

The Use of Artificial Intelligence Generated Contours in Radiation Planning of the Prostate Brachytherapy
Principal investigator · Active not recruiting
Brigham and Women's Hospital
2026–2028
INTREPId (INTermediate Risk Erection PreservatIon Trial)
Principal investigator · Active not recruiting · Phase 2
Brigham and Women's Hospital
2020–2028
A Pilot Study of Quantitative Tumor Oxygen Measurements in Cervical Cancer
Principal investigator · Active not recruiting
Brigham and Women's Hospital
2019–2026
Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer
Principal investigator · Terminated · Phase 1
Dana-Farber Cancer Institute
2018–2022